Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database

BACKGROUND: Accelerated treatment strategy, including tight disease control and early aggressive therapy with immunosuppressives (IS) and biological agents have become increasingly common in inflammatory bowel disease (IBD). The aim of the present study was to estimate the early treatment strategy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurti, Zsuzsanna, Ilias, Akos, Gonczi, Lorant, Vegh, Zsuzsanna, Fadgyas-Freyler, Petra, Korponay, Gyula, Golovics, Petra A., Lovasz, Barbara D., Lakatos, Peter L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789702/
https://www.ncbi.nlm.nih.gov/pubmed/29378524
http://dx.doi.org/10.1186/s12876-018-0746-6

Ejemplares similares

Ejemplares similares